PVLA
PALVELLA THERAPEUTICS, INC. · Healthcare · Market cap $1.8B
Insiders sold $9.7M net in the last 90 days ·3 sellers, 0 buyers· 9 of 10 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 14, 2026
Insider Buying
$850K
reported purchases (SEC code P)
Insider Selling
$13.3M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Oct 14, 2026
JENKINS GEORGE M
PALVELLA THERAPEUTICS, INC. (PVLA) has 18 SEC Form 4 filings (87 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Oct 14, 2026.
Inside the rolling window, 4 insiders at PALVELLA THERAPEUTICS, INC. reported 3 open-market purchases totaling $850K and 18 open-market sales totaling $13.3M. The most active filer is Chief Operating Officer Goin Kathleen with 11 filings. Insiders have net sold $10.7M over the trailing 6 months. The most recent open-market filing is a sale of 13,152 shares by Director JENKINS GEORGE M, dated Oct 12, 2026, worth $1.8M.
- Industry:Biotechnology
- CEO:Wesley H. Kaupinen
- Employees:29
- HQ:Wayne, PA, US
- IPO:2015-01-02
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Director | Sale | 13,152 | $1.8M | Oct 14 | +1.1% | SEC ↗ | |
| Director | Sale | 7,174 | $935K | Oct 14 | +1.1% | SEC ↗ | |
| Director | Sale | 7,174 | $886K | Oct 14 | — | SEC ↗ | |
| Chief Operating Officer | Sale | 4,302 | $655K | Sep 18 | — | SEC ↗ | |
JENKINS GEORGE MFirst in 6 months | Director | Sale | 12,371 | $1.9M | Sep 16 | — | SEC ↗ |
JENKINS GEORGE MFirst in 6 months | Director | Sale | 13,352 | $2.0M | Sep 16 | — | SEC ↗ |
JENKINS GEORGE MFirst in 6 months | Director | Sale | 1,777 | $267K | Sep 16 | — | SEC ↗ |
KIRITSY CHRISTOPHER PFirst filing | Director | Sale | 313 | $49K | Sep 4 | — | SEC ↗ |
| Chief Operating Officer | Sale | 4,302 | $655K | Aug 20 | — | SEC ↗ | |
| Chief Operating Officer | Sale | 4,302 | $642K | Jul 17 | — | SEC ↗ | |
| Chief Operating Officer | Sale | 4,302 | $476K | Jun 22 | — | SEC ↗ | |
| Chief Operating Officer | Sale | 4,302 | $476K | May 22 | — | SEC ↗ | |
| Chief Operating Officer | Sale | 4,302 | $547K | Apr 17 | — | SEC ↗ | |
| Director | Purchase | 445 | $50K | Apr 1 | — | SEC ↗ | |
| Chief Operating Officer | Sale | 4,302 | $508K | Mar 20 | — | SEC ↗ | |
HERON ELAINE JFirst in 3 months | Director | Purchase | 2,400 | $300K | Mar 2 | — | SEC ↗ |
JENKINS GEORGE MFirst filing | Director | Purchase | 4,000 | $500K | Mar 2 | — | SEC ↗ |
| Chief Operating Officer | Sale | 4,302 | $342K | Feb 20 | — | SEC ↗ | |
| Chief Operating Officer | Sale | 4,302 | $420K | Jan 23 | — | SEC ↗ | |
| Chief Operating Officer | Sale | 4,302 | $415K | Dec 19 | — | SEC ↗ | |
Goin KathleenFirst filing | Chief Operating Officer | Sale | 4,302 | $371K | Nov 21 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does PVLA have?
PALVELLA THERAPEUTICS, INC. (PVLA) has 18 SEC Form 4 filings (87 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Oct 14, 2026.
When was the most recent SEC Form 4 filing for PVLA?
The most recent Form 4 filing for PVLA on Tracefour is dated Oct 14, 2026.
Who is the most active insider at PVLA?
The most active SEC Form 4 filer at PVLA in the rolling window is Chief Operating Officer Goin Kathleen, with 11 filings.
What is the net insider flow at PVLA over the last 6 months?
Over the trailing 180 days, insiders at PVLA have net sold $10.7M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at PVLA in the current window?
Inside the rolling window, insiders at PVLA bought $850K and sold $13.3M based on SEC Form 4 filings.
Can I get alerts for PVLA insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at PALVELLA THERAPEUTICS, INC. (PVLA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
PALVELLA THERAPEUTICS, INC. is in the Healthcare sector.